Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity
2001 ◽
Vol 45
(2)
◽
pp. 208-216
◽
1995 ◽
Vol 2
(1)
◽
pp. 91-97
◽
1987 ◽
Vol 166
(1)
◽
pp. 271-276
◽
Keyword(s):
1998 ◽
Vol 5
(1)
◽
pp. 54A-54A
◽
1991 ◽
Vol 29
(3)
◽
pp. 267
◽
1996 ◽
Vol 67
(1)
◽
pp. 67-70
◽
1981 ◽
Vol 1
(2)
◽
pp. 253-262
◽